View by Specialty

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Optometry News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 22, 2024
2 min read
Save

Student loans: Let’s talk about SAVE

Student loans: Let’s talk about SAVE

The Savings on a Valuable Education (SAVE) plan was introduced in 2023 by the Biden Administration and replaces the Revised Pay As You Earn (REPAYE) program. SAVE continues to evolve with new benefits for student loan borrowers.

SPONSORED CONTENT
July 21, 2024
4 min watch
Save

VIDEO: Axitinib implant addresses sustainability in wet AMD

VIDEO: Axitinib implant addresses sustainability in wet AMD

In this Healio Video Perspective from the ASRS meeting, Pravin U. Dugel, MD, of Ocular Therapeutix discusses the phase 3 program for Axpaxli, an axitinib implant for wet age-related macular degeneration.

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

SPONSORED CONTENT
July 20, 2024
5 min watch
Save

VIDEO: Triamcinolone acetonide an option in those with uveitic macular edema, IOP issues

VIDEO: Triamcinolone acetonide an option in those with uveitic macular edema, IOP issues

In this Healio Video Perspective from the ASRS meeting, Danny Mammo, MD, of Cole Eye Institute discusses the real-world effect of triamcinolone acetonide on IOP in patients with uveitic macular edema.

SPONSORED CONTENT
July 19, 2024
3 min watch
Save

VIDEO: Phase 3 bel-sar trial focuses on choroidal melanoma

VIDEO: Phase 3 bel-sar trial focuses on choroidal melanoma

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Jill Hopkins, MD, of Aura Biosciences discusses a phase 3 program in ocular oncology.

SPONSORED CONTENT
July 19, 2024
3 min read
Save

Q&A: 72% of eye drop medication wasted due to ‘self-imposed use cessation dates’

Q&A: 72% of eye drop medication wasted due to ‘self-imposed use cessation dates’

Multiuse eye drop bottles are often discarded at medical centers long before the FDA-regulated expiration date, leading to significant drug waste and increased costs, according to research published in Ophthalmology.

SPONSORED CONTENT
July 19, 2024
2 min read
Save

4D-150 reduces annualized anti-VEGF injection rate in wet AMD at 24 weeks

4D-150 reduces annualized anti-VEGF injection rate in wet AMD at 24 weeks

One intravitreal injection of 4D-150 helped reduce the mean annualized anti-VEGF injection rate in patients with wet age-related macular degeneration, according to a study presented at the American Society of Retina Specialists meeting.

SPONSORED CONTENT
July 19, 2024
4 min watch
Save

VIDEO: ONL1204 slows geographic atrophy lesion growth in phase 1b study

VIDEO: ONL1204 slows geographic atrophy lesion growth in phase 1b study

In this Healio Video Perspective from the ASRS meeting, Durga Borkar, MD, of Duke University Eye Center presents data from a phase 1b study investigating ONL1204, a Fas inhibitor, for geographic atrophy.

SPONSORED CONTENT
July 18, 2024
1 min read
Save

Topical antibiotics may be overprescribed in children with conjunctivitis

Topical antibiotics may be overprescribed in children with conjunctivitis

Overtreating acute conjunctivitis with topical antibiotics may contribute to antibiotic resistance with no improvement in outcomes, according to a research letter published in JAMA Ophthalmology.

SPONSORED CONTENT
July 18, 2024
1 min read
Save

Safety, efficacy consistent in Luxturna post-authorization study

Safety, efficacy consistent in Luxturna post-authorization study

Interim safety data from a post-authorization study of Luxturna in patients with genetic retinal diseases were consistent with clinical trial data, according to a presentation at the American Society of Retina Specialists annual meeting.

SPONSORED CONTENT
July 18, 2024
1 min read
Save

AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD

AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD

Taking a daily supplement with antioxidant vitamins and minerals may slow the progression of late-stage dry age-related macular degeneration and could help maintain central vision in affected patients, according to researchers at NIH.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails